News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EOS Imaging (Formerly Known as biospace med) Obtains Regulatory Authorization to Sell Its Products in Japan


10/24/2013 10:29:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(NYSE Euronext, FR0011191766-EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced that Japanese regulatory authorities have authorized the sale of EOS® and sterEOS®. EOS imaging’s medical imaging system, which is comprised of EOS® and sterEOS®, offers very low radiation dose 2D and 3D X-ray imaging of the full body in a natural weight-bearing position (standing or sitting). It has already been approved for sale in more than 30 countries.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES